The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Type of prior genotoxic insult determines the genomic characteristics of therapy-related acute myeloid leukemia.
 
Michael Ozga
No Relationships to Disclose
 
James Stewart Blachly
Honoraria - LifeSci Venture Partners
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; Kite, a Gilead company
Patents, Royalties, Other Intellectual Property - Sequencing Technology patent pending (Inst)
Travel, Accommodations, Expenses - Oxford Nanopore Technologies
 
Nicole Renee Grieselhuber
No Relationships to Disclose
 
Karilyn T.M. Larkin
No Relationships to Disclose
 
Alison R. Walker
Research Funding - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Bhavana Bhatnagar
No Relationships to Disclose
 
Gregory Behbehani
No Relationships to Disclose
 
Meixiao Long
No Relationships to Disclose
 
Tamanna Zohra Haque
No Relationships to Disclose
 
Sumithira Vasu
No Relationships to Disclose
 
Weiqiang Zhao
No Relationships to Disclose
 
Daniel Jones
No Relationships to Disclose
 
John C. Byrd
Consulting or Advisory Role - Acerta Pharma; Genentech; Jazz Pharmaceuticals; Pharmacyclics
Research Funding - Acerta Pharma (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst)
 
Alice S. Mims
Consulting or Advisory Role - Abbvie/Genentech; Agios; Astellas Pharma; Jazz Pharmaceuticals; PTC Therapeutics
 
Caner Saygin
No Relationships to Disclose